Free Trial of Humanized Animal Models – 5 Free Humanized KnockIn Mice Offer!
September 4, 2023
This promotion has ended, please check out our Humanized Animal Models and Cell lines instead. New Year. New Research Opportunities. Our Therapeutic Focus Biocytogen’s Preclinical Services Division has established comprehensive in vivo and in vitro pharmacology capabilities and provides world-class services to our customers. Our team has significant expertise in testing novel therapeutics for immuno-oncology, […]
Biocytogen Establishes Two Business Divisions to Distinguish Preclinical Models and Services (BioMice) From Antibody Drug R&D
August 30, 2023
Beijing, China, August 31, 2023 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces the official formation of two major business divisions to represent the company’s product, service, and asset portfolio. Over the last decade, Biocytogen has developed several technology platforms to streamline the entire drug development process, including generation of specialized (humanized) […]
Eucure and Syncromune Establish Technology Transfer Agreement for YH002 (OX40 Antibody) and Multiple Other Clinical-Stage Antibodies
August 30, 2023
BEIJING, China, August 30, 2023 – Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that the company has entered into a technology transfer agreement with Syncromune, Inc. (“Syncromune”), a US-based clinical-stage biopharmaceutical company focused on the development of SYNC-T™, a platform technology designed to […]
Meet Us at Our Booth in JCA2023!
August 24, 2023
Biocytogen’s Asia-Pacific business development team is pleased to exhibit at the 82nd annual meeting of the Japanese cancer association, taking place from September 21–23, 2023 in Yokohama, Japan! Join us at Booth #42 to learn more about how BioMice® models and services, our fully human antibody discovery platforms and antibody assets can accelerate your R&D […]
Biocytogen’s Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth
August 17, 2023
BEIJING, China–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced today that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth. Project Integrum is a large-scale R&D project designed to discover novel therapeutic antibodies for more than 1000 druggable targets. The project, which […]
Biocytogen Announces Grand Opening of Waltham, MA Facility
August 16, 2023
State-of-the-Art Facility Signifies Growth of Business in North America and Europe August 16, 2023, Waltham, MA & Beijing, China – Biocytogen Pharmaceuticals (HKEX: 02315; “Biocytogen”), a biotechnology company focused on the generation and validation of novel antibody-based therapeutics and specialized animal models for partners worldwide, today announces the grand opening of a new 37,000 sqft. […]
Webinar: Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform
August 4, 2023
Our webinar “Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform” was live at 11:00 AM EDT on Aug 30th, 2023. About the Webinar GPCRs (G protein-coupled receptor) are the most abundant membrane protein in the human genome, and are targeted by approximately one-third of drugs on the market. However, the difficulty in antigen preparation […]
Join us at the 11th Annual Immuno-Oncology Summit: Aug 7-9
Join us at the 11th Annual Immuno-Oncology Summit from August 7-9 in Boston! Learn more about our in vivo efficacy, PK/PD, toxicity, and in vitro pharmacology platforms. Attend the meeting Talk to us at the booth! CHI’s IO Summit provides access to a comprehensive 3-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore […]
Join us at Basic Cardiovascular Sciences Scientific Sessions 2023: July 31–August 3
July 25, 2023
Join us at the Basic Cardiovascular Science Event from July 31-August 3 in Boston! Learn more about how our gene editing services and animal models can support your research needs. Attend the meeting Talk to us at the booth! The annual BCVS Scientific Sessions is one of largest meetings in the world dedicated to fundamental […]
Meet us at BIO Asia-Taiwan!
July 19, 2023
Biocytogen’s Asia-Pacific business development team is pleased to host online 1-on-1 meetings at BIO Asia-Taiwan, taking place from July 25-26, 2023! Chat with our team to learn more about our animal models, preclinical services and antibody assets in discovery. Schedule a Meeting with Us BioMice: Innovative Models to Empower Health Sciences BioMice is a sub-brand […]